Cohort Study for Gastric MALT Lymphoma

Seoul National University Hospital300 enrolled

Overview

The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls. Participants will be asked to provide clinical information and various tissues (saliva, gastric mucosa, and feces).

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Gastric MALT Lymphoma

Interventions

MALT lymphomaOTHER

New diagnosis with gastric MALT lymphoma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \[MALT lymphoma group\] * Newly diagnosed as gastric MALT lymphoma \[Control group\] * Patients who underwent 1. diagnosed upper endoscopy for dyspepsia and had chronic gastritis, 2. therapeutic upper endoscopy for gastric hyperplastic polyps, or 3. screening upper endoscopy without any symptoms. Exclusion Criteria: * History of gastric or other malignancy * Use of antibiotics or probiotics within 4 weeks * Uncontrolled chronic illnesses

Locations (3)

Korea University Ansan Hospital

Ansan-si, Gyeonggi-do, South Korea

NOT_YET_RECRUITING

Cheol Min Shin

Seongnam-si, Gyeonggi-do, South Korea

RECRUITING

Kangbuk Samsung Hospital

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Remission of gastric MALT lymphoma

Time frame: Within 3 years from diagnosis

Secondary Outcomes

Eradication of H. pylori infection

Time frame: Within 6 month from eradication therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.